Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-07-19
1995-10-10
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540 49, 540 58, C07J 100, A61K 3156
Patent
active
054570972
ABSTRACT:
This invention refers to compounds of formula (I) ##STR1## wherein x, y, z represent single or double bonds;
REFERENCES:
patent: 3032551 (1962-05-01), Orr et al.
patent: 3282928 (1966-11-01), Cantrall et al.
patent: 4757061 (1988-07-01), Faustini et al.
patent: 4822528 (1989-04-01), Columbo et al.
patent: 4824830 (1989-04-01), Buzzetti et al.
patent: 4873233 (1989-10-01), Villa et al.
Biochemical Pharmacology, vol. 34, pp. 3213-3219 (1985).
Drugs of the Future, vol. 17, pp. 278-280 (1992).
Drugs of the Future, vol. 18, pp. 599-600 (1993).
Therapeutic Patents, Jun. 1993.
Chemical & Pharmaceutical Bulletin, vol. 17, No. 12, Dec. 1969, pp. 2586-2598, Taichiro Komeno, et al., "Thiosteroids. XXII. The Intramolecular Cyclization of 6-Acylthio-, Acyloxy-, and Acylamino-4-En-3-One Steroids. Pentacyclic Steroids".
Buzzetti Franco
Di Salle Enrico
Longo Antonio
Farmitalia Carlo Erba S.r.l.
Rizzo Nicholas
LandOfFree
Androst-4-eno[4,5-b]pyrrole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androst-4-eno[4,5-b]pyrrole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androst-4-eno[4,5-b]pyrrole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310498